Shared Research logo
Conclusion of a sublicensing agreement for the sales rights of Sancuso and episil, announcement of dissolving of Chinese subsidiary's sales network
Capital and business alliance with Nippon Kayaku and issuance of new shares via third-party allotment
Obtained marketing approval for Darvias Injection 135mg
Get in touch
4F, Sumitomo Fudosan Shiba-koen Tower, 2-11-1, Shiba-koen, Minato-ku, Tokyo 105-0011, Japan
Solasia Pharma is a biotech venture that in-licenses development and sales rights for new drugs developed in the US and Europe to commercialize them in Japan and other parts of Asia.